These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6165854)

  • 1. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
    Presant CA; Coulter D; Valeriote F; Vietti TJ
    J Natl Cancer Inst; 1981 Jun; 66(6):1151-4. PubMed ID: 6165854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
    Presant CA; Vietti T; Valeriote F
    Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA; Valeriote F; Vietti TJ
    Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of cytosine arabinoside and thiopurines.
    Valeriote F; Vietti T; Edelstein M
    Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.
    Santelli G; Valeriote F
    Cancer Chemother Pharmacol; 1986; 18(2):101-4. PubMed ID: 3791555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
    Vietti TJ; Valeriote FA; Kalish R; Coulter D
    Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.
    Kelly CJ; Gaudio L; Yesair DW; Schoenemann PT; Wodinsky I
    Cancer Treat Rep; 1978 Jul; 62(7):1025-32. PubMed ID: 80268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine.
    Neil GL; Berger AE; Bhuyan BK; DeSante DC
    Cancer Res; 1976 Mar; 36(3):1114-20. PubMed ID: 56229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of nitrogen mustard cytotoxicity by disulfiram, diethyldithiocarbamic acid, and diethylamine in mice.
    Valeriote F; Grates HE
    Cancer Res; 1989 Dec; 49(23):6658-61. PubMed ID: 2555050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T 1/2 clone 8 and V79 cells.
    Landolph JR; Jones PA
    Cancer Res; 1982 Mar; 42(3):817-23. PubMed ID: 6174215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Tocopherol pretreatment increases adriamycin bone marrow toxicity.
    Alberts DS; Peng YM; Moon TE
    Biomedicine; 1978 Oct; 29(6):189-91. PubMed ID: 737277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclophosphamide on mouse bone marrow and leukemic stem cells.
    Paprocka M; Budzyński W; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1980; 28(3):447-51. PubMed ID: 7447649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.
    Presant CA; Vietti TJ; Valeriote F; Coulter DM
    J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydro-5-azacytidine hydrochloride, a biologically active and chemically stable analog of 5-azacytidine.
    Beisler JA; Abbasi MM; Driscoll JS
    Cancer Treat Rep; 1976 Nov; 60(11):1671-4. PubMed ID: 66095
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of aclacinomycin-A on murine leukemia.
    Nara N; Miyamoto T; Hirashima K; Momoi H
    Blood; 1982 Jul; 60(1):188-93. PubMed ID: 6952948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of nitrogen mustard cytotoxicity to leukemia cells by sulfur-containing compounds administered in vivo.
    Valeriote F; Grates HE
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1165-9. PubMed ID: 3744935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
    Naujokaitis SA; Fisher JM; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):305-18. PubMed ID: 7302378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the in vitro cytotoxicity (L1210) of 5-aza-2'-deoxycytidine with its therapeutic and toxic effects in mice.
    Covey JM; Zaharko DS
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):109-17. PubMed ID: 2578963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.